With a $30,000 grant from FRAXA Research Foundation in 1999, Dr. Paul Hagerman and his team at the University of California researched how to re-activate the FMR1 gene and how to measure its levels.

Paul Hagerman, PhD, Investigator at UC Davis MIND Institute, researches the molecular and genetic sources for the fragile X gene, as well as developing targeted treatments for Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
With a $30,000 grant from FRAXA Research Foundation in 1999, Dr. Paul Hagerman and his team at the University of California researched how to re-activate the FMR1 gene and how to measure its levels.